Watertown, MA. October 30th, 2020. Respiratory Motion, Inc. (RMI) is pleased to announce the appointment of CareVie Medical as the general agent responsible for distribution of for the ExSpiron® for minute ventilation monitoring in Europe, Middle East and Africa with the exception of Benelux. CareVie Medical will be responsible for appointing local distributors by country and for logistics, service and sales support.
“We are delighted to have CareVie Medical as a partner as we expand in international markets,” said Laura Piccinini, CEO of RMI. “The team at CareVie Medical brings deep understanding of the respiratory space and a network of strong distributors.”
“We welcome RMI to our portfolio of products,” said Leo Brouwer, CEO of CareVie Medical. “The ExSpiron technology is a useful tool for assessing respiratory status in a way not currently delivered by any competing technology.”
About CareVie Medical
CareVie Medical, located in Freienbach, Switzerland, care for lives. We strive to decrease workload for caregivers and optimize patient outcomes by bringing innovative products, focused on respiratory to physicians and nurses. Together with our business partners, we challenge ingrained thought patterns and dare to go new pathways - for the benefit of our customers and patients.